ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 180973 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 180973; 2) Community: the network communities that were significantly associated with the response to NSC 180973; 3) Molecule: the relationships between components within communities and NSC 180973; 4) MDR: the compounds that were significantly associated with the NSC 180973.

NSC Compound Enrichment Correlation
NSC 751500 Null 0.0459335986102865 0.35116666
NSC 751958 (2E)-2-(all-trans retinylidene)-N-{[(2E)-2-(all-trans retinylidene)hydrazinyl]carbonothioyl}hydrazinecarbothioamide N3-monosodium salt heminonahydrate 0.0459335986102865 0.19017748
NSC 752892 N-[4-(4-Benzoylamino-pyrrolo[3,2-c]pyridin-1-yl)-phenyl]-4-(4-morpholin-4-yl)-3-trifluoromethylbenzamide 0.0459335986102865 0.42467841
NSC 758845 Null 0.0459335986102865 0.15875295
NSC 762009 Copper(II) complex with quin as a ligand 0.0459335986102865 0.33586948
NSC 7811 Ammonium, [4-[[p-(dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-ylidene]dimethyl-, chloride (8CI) 0.0459335986102865 0.18258792
NSC 87500 Solacongestidine 0.0459335986102865 0.27777438
NSC 686560 [Di-17.alpha./.beta.-(2-ethoxy-3-hydroxyestra-1,3,5(10)-triene)-]sulphite 0.0459335986102869 0.21458571
NSC 222722 Null 0.0462077035966084 0.25005265
NSC 236580 .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone 0.0462077035966084 0.36027972
Total:107  Current:97    [First] [Prev] [Next] [Last]